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Then, the reaction mixture was filtered and the residue (2.00 g, 7.80 mmol, 1.0 equiv.) was diluted with THF (30 mL). Afterward, NaBH4 (0.295 g, 7.80 mmol, 1.0 equiv.) was added and stirred at room temperature for 2 h. Then, water (5 mL) was added into the reaction mixture and THF was removed under reduced pressure. The residue was extracted with dichloromethane (DCM) and the organic phase was dried over anhydrous Na2SO4, yielding (4-((2-nitrobenzyl)amino)phenyl)methanol as orange oil.
Next, (4-((2-nitrobenzyl)amino)phenyl)methanol (1.03 g, 3.97 mmol, 1.0 equiv.) was dissolved in acetic acid (20 mL) and NaNO2 (0.30 g, 4.41 mmol, 1.1 equiv.) aqueous solution (60 mL) was added dropwise. The mixture was stirred at room temperature for 20 min and was then poured into a saturated NaHCO3 solution (Caution! CO2 gas generation). The aqueous phase was extracted with DCM (60 mL × 5) and the combined organic phase was dried over Na2SO4. After removing DCM by a rotary evaporator, the residue was purified by column chromatography, yielding N-(4-(hydroxymethyl)phenyl)-N-(2-nitrobenzyl)nitrous amide as a light yellowish solid (0.73 g, yield: 64%). Next, N-(4-(hydroxymethyl)phenyl)-N-(2-nitrobenzyl)nitrous amide (0.73 g, 2.54 mmol, 1.0 equiv.), 2-isocyanatoethyl methacrylate (0.39 g, 2.54 mmol, 1.0 equiv.), and DBTL (11 μL) were dissolved in THF (20 mL) and were stirred at room temperature overnight. After removing the organic solvent, the solid residue was further purified by column chromatography, yielding oNBN monomer as yellowish solid (0.95 g, yield:
84.8%).
BN and pNBN monomers were synthesized using a similar protocol and the synthetic procedure is shown in Scheme 2a. During the preparation process, benzaldehyde or p- 1.04 mmol, 1.0 equiv.), 4-nitrophenyl isocyanate (0.17 g, 1.04 mmol, 1.0 equiv.), and DBTL (5 μL) were dissolved in THF (20 mL), and were stirred at room temperature overnight. After removal of THF under vacuum, the reaction mixture was purified by column chromatography to obtain the named product (0.41 g, yield: 87.2%).
Synthesis of PEO-b-PoNBN Amphiphiles (Scheme 2b). Typically, oNBN monomer (442 mg, 1.00 mmol, 50.0 equiv.), PEO-based macroRAFT agent (45 mg, 0.02 mmol, 1.0 equiv.), and AIBN (0.33 mg, 0.002 mmol, 0.1 equiv.) were dissolved in DMSO (0.7 mL) and were added into a sealed tube. The tube was degassed by three freeze−pump−thaw cycles and then sealed under vacuum. After stirring at 70 o C for 8 h, the polymerization reaction was quenched by immersing the reaction tube into liquid nitrogen. The tube was then opened, exposed to air, diluted with DCM, and precipitated into an excess of diethyl ether. The above dissolutionprecipitation cycle was repeated three times. The precipitate was then collected by filtration and was dried in a vacuum oven overnight at room temperature, affording a yellowish solid (120 mg, yield: 24.6%). The degree of polymerization (DP) of the PoNBN block was calculated to be ∼25 by 1 H NMR analysis (Table S1 and Figure S18a) ; thus, the diblock copolymer was denoted as PEO45-b-PoNBN25 (BP1 , Table S1 ).
To prepare the PEO-b-PpNBN (BP2) and PEO-b-PBN (BP3) diblock copolymers, pNBN and BN monomers were used instead of oNBN. The structural parameters of the synthesized PEO45-b-PpNBN30 (BP2) and PEO45-b-PBN46 (BP3) are summarized in Table S1 .
Self-Assembly of PEO-b-PoNBN Amphiphiles. 5 mg of BP1 was dissolved in 1,4-dioxane (1 mL), and the solution was stirred at 25 o C for 30 min. Then, 0.5 mL of pure water was slowly added at 1 mL/h via a syringe pump. The mixture was then extruded through a syringe filter (220 nm) four times. After that, pure water (2.5 mL) was then injected to frozen the assemblies at a rate of 1 mL/h. 1,4-Dioxane was removed by dialysis (MWCO 3.0 kDa) against pure water or PBS buffer solution (pH 7.4, 10 mM). For the self-assembly of BP2 diblock copolymers, 1 mg of BP2 was dissolved in 1,4-dioxane (1 mL), and the solution was stirred at 25 o C for 30 min. Then, 9 mL of deionized water was injected at a rate of 1 mL/h using a syringe pump. After the water addition, the organic solvent (i.e., 1,4-dioxane) was removed by dialysis (MWCO 3.0 kDa) against deionized water.
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Preparation of DOX-Loaded BP1 Vesicles. 5 mg of BP1 was dissolved in 1,4-dioxane (1 mL), and the solution was stirred at 25 o C for 30 min. Then, 0.5 mL of DOX·HCl aqueous solution (20 mg/mL) was slowly added at 1 mL/h via a syringe pump. After addition, the mixture was extruded through a syringe filter (220 nm) four times. After that, 1.5 mL of DOX·HCl aqueous solution (20 mg/mL) was added within 1.5 h. Afterward, 1,4-dioxane and unloaded DOX·HCl were removed by dialysis (MWCO 3.0 kDa) against deionized water. In a similar protocol, Nile red (NR)-loaded vesicles were also prepared and the unloaded NR was removed by exhaustive dialysis against deionized water.
Light-Triggered Release of DOX. 400 μL of the as-prepared DOX-loaded BP1 vesicles without or with 365 nm irradiation was dialyzed against 10 mL of pure deionized water. At predetermined time points, the dialysate was replaced with 10 mL of fresh deionized water. The dialysate was subjected to lyophilization and the solid residues were re-dissolved in 1mL of DMSO/H2O (v/v = 3/1). The DOX concentration was determined by fluorescence spectroscopy against a standard calibration curve. To establish a standard calibration curve of DOX, a series of DOX solutions (0.078125 nM -10 μΜ) in DMSO/H2O (v/v = 3/1) were prepared and the corresponding fluorescence spectroscopy was measured. The excitation and emission wavelengths were set at 480 nm and 593 nm, respectively.
In Vitro Cytotoxicity Assay. Cell viability was examined by the Alamar blue assay. Briefly, human corneal epithelial cells (HCECs) were seeded in a 96-well plate at an initial density of 10,000 cells/well in 100 μL of DMEM complete medium. After incubation for 24 h, the culture medium was removed. BP1 vesicles were diluted with DMEM complete medium or PBS buffer (pH 7.4, 10 mM), and then 100 μL of mixture solutions were added to 96-well plate to achieve different polymersomes concentrations (0.4, 0.2, 0.1, 0.05, 0.02, 0.01 g/L). After incubation for 4 h, the mixture solutions were removed and the 96-well plate was rinsed with 100 μL of PBS three times. Afterward, the plate was irradiated with a hand-held UV lamp for varying times (e.g., 0, 5, 10, or 20 min). After irradiation, the PBS in each well was removed and was replaced by 100 μL of DMEM complete medium. The cells were incubated for another 24, 48, 72, and 88 h and Alamar blue reagent (10 μL, Thermo Fisher) was added to each well. After the addition, the cells were further incubated with 5% CO2 for 4 h at 37 °C. The fluorescence emission at Determination of NO Contents Using Griess Assay. 3 mL of BP1 vesicle dispersion or NO-releasing precursors (40 μM) were placed in a standard quartz cuvette. The sample was irradiated with a hand-held UV lamp (365 nm, 4 mW/cm 2 ) and an aliquot sample (150 μL) was periodically withdrawn at predetermined time points. The irradiated sample was mixed with an equal volume of Griess reagent (Sigma-Aldrich, product number: 03553) and was incubated at room temperature under dark condition for 10 min. The nitrite concentration was determined by UV-vis spectroscopy based on the absorbance intensity at 526 nm against a standard calibration curve.
In vitro Scratch Assay. Human corneal epithelial cells (HCECs) were seeded in a 96-well plate at an initial density of 6 × 10 4 cells/well in 100 μL of DMEM complete medium. After a confluent monolayer was formed, the culture medium was removed. The cell monolayers were scraped with a p200 pipet tip to form a straight line. 5 The debris was removed by carefully washing the cells with PBS. Next, BP1 vesicles (the final concentration was fixed at 0.1 mg/mL) or PBS (pH 7.4, 10 mM) or GSNO was added and the cells were further incubated for 4 h.
Afterward, 100 μL of DMEM complete medium was added and the cells after coincubation with BP1 vesicles were irradiated with a hand-held UV lamp for 0 min, 5 min, or 10 min, respectively. The plates were further incubated at 37 o C and the cells were imaged on a phasecontrast microscope at a predetermined time.
Photo-Mediated Intracellular NO Release Observed by Confocal Laser Scanning
Microscopy (CLSM). Briefly, HeLa cells were seeded in a 4-well plate at an initial density of 150,000 cells/well in 500 μL of DMEM complete medium. After incubation for 8 h, the culture medium was removed and BP1 vesicles (0.4 g/L, 500 μL) in DMEM complete medium was S7 added; the cells were further incubated for 8 h prior to the addition of pyronine probe (0.1 mM).
After 30 min incubation, the cells were irradiated with or without 365 nm hand-held UV lamp for 20 min. Then, the culture medium was removed and rinsed with PBS buffer. The cells were imaged by CLSM. The excitation wavelength was set at 514 nm and the red channel was set at 580-630 nm. Each treatment group consisted of four corneas and the treatment was implemented every 8
In vivo
hour. The corneal epithelial defects were recorded by a 0.5% fluorescein sodium solution at predetermined times. The stained corneas were imaged by a hand-held Dino-Lite digital microscope (AM5218MZT) and the wound areas were analyzed by calculation of the stained areas using ImageJ software.
Characterization.
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AV300 NMR (300 MHz) spectrometer operated in the Fourier transform mode. Deuterated chloroform (CDCl3) and dimethyl sulfone (DMSO-d6) were used as the solvents. Molecular weights and molecular Fluorescence spectra were performed on an F-4600 (Hitachi) spectrofluorometer. Dynamic laser light scattering (LLS) measurements were conducted on a Zetasizer Nano ZS (Malvern).
The scattered light was collected at a fixed angle of 173 o for the duration of ~5 min. All data were averaged over three consecutive measurements. Electron paramagnetic resonance (EPR)
spectroscopy was recorded on a JES-FA200 (JEOL) spectrometer. The measurements were conducted at room temperature and the following parameters were used: modulation frequency: 
Statistical Analysis
The results are expressed as mean ± standard deviation (s.d. 26, 156.14, 147.46, 141.21, 136.05, 135.90, 134.17, 129.49, 129.43, 128.66, 127.53, 126.10, 125.78, 118.76, 65.89, 63.62, 45.82, 40.29, 18 .29. 
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C NMR (400 MHz, δ, ppm): 166.96, 156.63, 147.18, 142.75, 140.67, 137.19, 136.20, 129.50, 128.59, 126.39, 124.31, 120.11, 65.05, 63.72, 46.35, 40.15 49, 141.55, 134.17, 129.76, 129.66, 128.62, 127.67, 127.63, 125.77, 118.90, 46. δ, ppm): 141.79, 134.30, 129.51, 128.86, 127.63, 127.39, 127.01, 119.56, 47.36 Figure S16 . ( 1 H NMR (400 MHz, δ, ppm): 10.55 (s, 1H), 8.21 (d, J = 9.3 Hz, 2H), 8.13 (dd, J = 8.1, 1.4 Hz, 1H), 4H), 4H), 6.94 (dd, J = 7.8, 1.4 Hz, 1H), 5.62 (s, 2H), 5.24 (s, 2H) .
C NMR (101 MHz, δ, ppm): 153.49, 148.10, 146.00, 142.22, 141.11, 136.03, 134.65, 130.02, 129.47, 129.35, 128.43, 125.86, 125.57, 120.19, 118.16, 66.20, 45.26 
